A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity
- PMID: 16159600
- DOI: 10.1016/j.atherosclerosis.2005.03.001
A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity
Abstract
Objective: Low levels of high density lipoprotein-cholesterol (HDL-C) are highly prevalent in subjects presenting premature atherosclerosis. It is indeterminate as to whether high cardiovascular risk in low HDL-C subjects occurs concomitantly with elevated oxidative stress and/or with biologically dysfunctional HDL particles.
Methods and results: Systemic oxidative stress (as plasma 8-isoprostanes) was 2.3-fold elevated (p<0.05) in normocholesterolemic, normotriglyceridemic, normoglycemic low HDL-C subjects (plasma HDL-C, <40 mg/dL; n=8) as compared to normolipidemic controls (n=15). HDL subfractions (HDL2b, 2a, 3a, 3b and 3c) isolated by density gradient ultracentrifugation from low HDL-C subjects displayed significantly lower (-21 to -43%, p<0.05) specific antioxidative activity (sAA; capacity to protect LDL from oxidation on a unit particle mass or on a particle number basis) as compared to controls. Altered chemical composition (core triglyceride enrichment, cholesteryl ester depletion) paralleled antioxidative dysfunction of HDL subfractions. Plasma 8-isoprostane levels negatively correlated with sAA of HDL subfractions and positively correlated with the total cholesterol/HDL-C ratio, which was significantly elevated in the low HDL-C phenotype.
Conclusions: Low HDL-C subjects display elevated oxidative stress and possess HDL particle subspecies with attenuated intrinsic antioxidative activity which is intimately related to their altered chemical composition.
Similar articles
-
Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity.J Clin Endocrinol Metab. 2004 Oct;89(10):4963-71. doi: 10.1210/jc.2004-0305. J Clin Endocrinol Metab. 2004. PMID: 15472192
-
Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):526-33. doi: 10.1161/01.ATV.0000118276.87061.00. Epub 2004 Jan 22. Arterioscler Thromb Vasc Biol. 2004. PMID: 14739123
-
Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.Diabetologia. 2005 Mar;48(3):529-38. doi: 10.1007/s00125-004-1655-5. Epub 2005 Feb 24. Diabetologia. 2005. PMID: 15729582
-
Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.Pharmacol Rev. 2006 Sep;58(3):342-74. doi: 10.1124/pr.58.3.1. Pharmacol Rev. 2006. PMID: 16968945 Review.
-
Alterations in lipoprotein defense against oxidative stress in metabolic syndrome.Curr Atheroscler Rep. 2006 Nov;8(6):501-9. doi: 10.1007/s11883-006-0026-8. Curr Atheroscler Rep. 2006. PMID: 17045077 Review.
Cited by
-
Oxidative Stress Underpins Clinical, Social, and Genetic Risk Factors for Atherosclerotic Cardiovascular Disease.Clin Med Insights Cardiol. 2023 Apr 29;17:11795468231170779. doi: 10.1177/11795468231170779. eCollection 2023. Clin Med Insights Cardiol. 2023. PMID: 37153696 Free PMC article.
-
Cholesterol in colorectal cancer: an essential but tumorigenic precursor?Front Oncol. 2023 Nov 3;13:1276654. doi: 10.3389/fonc.2023.1276654. eCollection 2023. Front Oncol. 2023. PMID: 38023258 Free PMC article. Review.
-
High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity.Metabolites. 2023 Feb 9;13(2):253. doi: 10.3390/metabo13020253. Metabolites. 2023. PMID: 36837872 Free PMC article. Review.
-
Mathematical Modelling of Material Transfer to High-Density Lipoprotein (HDL) upon Triglyceride Lipolysis by Lipoprotein Lipase: Relevance to Cardioprotective Role of HDL.Metabolites. 2022 Jul 6;12(7):623. doi: 10.3390/metabo12070623. Metabolites. 2022. PMID: 35888747 Free PMC article.
-
High-Density Lipoprotein in Metabolic Disorders and Beyond: An Exciting New World Full of Challenges and Opportunities.Pharmaceuticals (Basel). 2023 Jun 8;16(6):855. doi: 10.3390/ph16060855. Pharmaceuticals (Basel). 2023. PMID: 37375802 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical